http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6141935

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 70
issn 1093-4715
1093-9946
issueIdentifier 1
pageRange 163-70
publicationName Frontiers in bioscience (Landmark edition)
startingPage 163
bibliographicCitation Berdeja JG. Lorvotuzumab mertansine: antibody-drug-conjugate for CD56+ multiple myeloma. Front Biosci (Landmark Ed). 2014 Jan 01;19(1):163–70. doi: 10.2741/4202. PMID: 24389179.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_601d151cde13ae6778dcfddbb2e5ca7f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4362-0376
date 2014-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/24389179
https://doi.org/10.2741/4202
isPartOf https://portal.issn.org/resource/ISSN/1093-4715
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29838
https://portal.issn.org/resource/ISSN/1093-9946
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma
discusses http://id.nlm.nih.gov/mesh/M0028376
http://id.nlm.nih.gov/mesh/M0013148
http://id.nlm.nih.gov/mesh/M0582676
http://id.nlm.nih.gov/mesh/M0028142
http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D018796Q000627
http://id.nlm.nih.gov/mesh/D008453Q000031
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D009101Q000628
http://id.nlm.nih.gov/mesh/D019002Q000276
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000911Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008453Q000627
http://id.nlm.nih.gov/mesh/D008453Q000009
http://id.nlm.nih.gov/mesh/D018796Q000009
http://id.nlm.nih.gov/mesh/D009101Q000276
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165363472
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11343137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274095
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57883097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91885467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131847656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72764735
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b60e7841ce141c73cb0fd4d93079c52d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71301226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118984478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123645457

Total number of triples: 56.